Amivantamab
61186372COR3001
Phase 3 mab active
Quick answer
Amivantamab for Colorectal Neoplasms is a Phase 3 program (mab) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Colorectal Neoplasms
- Phase
- Phase 3
- Modality
- mab
- Status
- active